Some Mendelian randomization analyses have supported the causal association of CRP with prostate cancer, whereas other data show that CRP concentrations are not predictive in clinically localized prostate cancer compared to advanced stages, with high levels correlating with metastases and poor survival [778,842]. Here, CRP is linked to prostate carcinoma.